🇺🇸 FDA
Patent

US 12319708

Agonists of peroxisome proliferator-activated receptor alpha (PPARα) and methods of use

granted A61PA61P29/00

Quick answer

US patent 12319708 (Agonists of peroxisome proliferator-activated receptor alpha (PPARα) and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P29/00